The aim of this pilot-study was to investigate the safety, feasibility and tolerability of an assisted mobilization of patients with advanced pulmonary diseases, using a lightweight, exoskeleton-type robot (Myosuit, MyoSwiss AG, Zurich, Switzerland). Ten patients performed activities of daily life (ADL) both with and without the device. The mean age was 53.
View Article and Find Full Text PDFAims: The aim of this pilot study was to investigate the safety, feasibility, tolerability, and acceptability of an assisted mobilization of advanced heart failure patients, using a lightweight, exoskeleton-type robot (Myosuit, MyoSwiss AG, Zurich, Switzerland).
Methods And Results: Twenty patients in functional NYHA class III performed activities of daily life (ADL, n = 10) or participated in a single, standardized, 60 min rehabilitation exercise unit (REU, n = 10) with and without the Myosuit. The outcome assessment included the evaluation of vital signs, adverse events, rates of perceived exertion and dyspnoea (RPE, RPD), the ability to perform ADL or REU, and the individual acceptability.
Arzneimittelforschung
October 1961
Arzneimittelforschung
August 1959
Arch Int Pharmacodyn Ther
December 1956
Antibiot Chemother (Northfield)
December 1955
J Pharmacol Exp Ther
September 1955
J Pharmacol Exp Ther
March 1953
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol
February 2004
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol
May 2003
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol
February 2004